glimepiride has been researched along with Parkinsonian Disorders in 1 studies
glimepiride: structure given in first source
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishola, IO | 1 |
| Akataobi, OE | 1 |
| Alade, AA | 1 |
| Adeyemi, OO | 1 |
1 other study available for glimepiride and Parkinsonian Disorders
| Article | Year |
|---|---|
Glimepiride prevents paraquat-induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation.
Topics: Animals; Antioxidants; Cytokines; Dose-Response Relationship, Drug; Inflammation; Lipid Peroxidation | 2019 |